Administered by slow intravenous infusion through a peripheral or central vein. The rate of administration should be carefully controlled by a healthcare professional based on the patient's metabolic needs and glucose tolerance.

Dextrose provides readily available carbohydrates, which are metabolized to produce energy, carbon dioxide, and water. It helps in maintaining fluid and electrolyte balance and prevents ketosis.

• •Known hypersensitivity to dextrose or corn products (if corn-derived).
• •Anuria (absence of urine production).
• •Diabetic coma (unless blood sugar is very low and insulin is administered concurrently).
• •Intracranial or intraspinal hemorrhage (due to potential for increased intracranial pressure).
• •Patients with known fructose-sorbitol intolerance (depending on source of dextrose).

Store below 30°C. Do not freeze. Protect from light. Keep out of reach of children. Use immediately after opening.

Overdose may lead to severe hyperglycemia, glycosuria, dehydration, electrolyte disturbances (e.g., hypokalemia, hypophosphatemia), and osmotic diuresis. Treatment involves discontinuing infusion, administering insulin if severe hyperglycemia, and correcting fluid/electrolyte imbalances.

Generally considered safe for use during pregnancy and lactation, as dextrose is a natural metabolic substrate. However, careful monitoring of maternal and fetal/infant blood glucose and electrolytes is recommended.